Key facts
- Atraverse Medical’s last known valuation is $22.5M (Nov 2023).
- It has raised $69.6M across 2 recorded rounds; the latest was Early Stage VC ($8.6M) in Apr 2025.
- Notable investors include CONNECT (San Diego), New York Angels, Band of Angels, MedTech Angels, HBS Alumni Angels of Greater New York — 7 tracked in total.
- Atraverse Medical has filed 2 Form Ds with the SEC, most recently May 2025 ($8.6M sold to 41 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Atraverse Medical
Funding rounds
2 roundsAbout Atraverse Medical
Developer of left-heart access equipment designed to simplify workflows and streamline procedures. The company is developing a toolset for left-heart access and standardizing procedures, and provides flexible transeptal access technologies to streamline procedures and improve patient outcomes, enabling doctors to improve patient outcomes.
- Sector
- Healthcare
- HQ
- Encinitas, CA, United States
- Founded
- 2022
- Employees
- 32
- Website
- atraversemedical.com/
- Ownership
- Privately Held (backing)
Atraverse Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atraverse Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atraverse Medical in its N-PORT filings yet. We sweep new filings monthly.